NervGen Pharma
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2955 Virtual Way Suite 480, Vancouver, B...Phone Number
(778) 731-1711Website
www.nervgen.comRevenue
-Stock Symbol
NGENIndustry
About NervGen Pharma
NervGen is restoring life's potential by developing innovative solutions for the treatment of nervous system injuries. The Company is developing drugs for the treatment of multiple sclerosis, spinal cord injury and Alzheimer's disease. NervGen's platform technology targets protein tyrosine phosphatase sigma ("PTP"), a neural receptor that impedes nerve repair. Inhibition of the PTP receptor has been shown to promote regeneration and remyelination of damaged nerves, as well as improvement of nerve function in animal models for various medical conditions.Explore more
SIC Code 28,283NAICS Code 32,325Ticker TSX: NGENShow moreNervGen Pharma Org Chart
Compare Similar Companies to NervGen Pharma
Compare insights from companies similar to NervGen Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
NervGen Pharma Tech Stack
A closer look at the technologies used by NervGen Pharma
See more technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding NervGen Pharma
Sign Up For FreeTo access detailed company insights
NervGen is restoring life's potential by developing innovative solutions for the treatment of nervous system injuries. The Company is developing drugs for the treatment of multiple sclerosis, spinal cord injury and Alzheimer's disease. NervGen's platform technology targets protein tyrosine phosphatase sigma ("PTP"), a neural receptor that impedes n... Read More